| Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336) |
|---|
| 05/27/2004 | WO2004043967A1 Spirocyclic cyclohexane derivatives |
| 05/27/2004 | WO2004043931A1 Propanamine derivatives as serotonin and norepinephrine reuptake inhibitors |
| 05/27/2004 | WO2003070245B1 Mono-ester and asymmetrically substituted di-ester pro-drugs of the dopamine d1 receptor agonists |
| 05/27/2004 | US20040102630 For therapy of cancer, auto-immune diseases, cardiovascular diseases, infectious diseases, nephrological diseases, neurodegenerative diseases and viral infections |
| 05/27/2004 | US20040102450 Substituted oxoazaheterocyclyl compounds |
| 05/27/2004 | DE10252667A1 New spiro-((cyclohexane)-tetrahydropyrano-(3,4-b)-indole) derivatives, are ORL1 receptor ligands useful e.g. for treating anxiety, depression, epilepsy, senile dementia, withdrawal symptoms or especially pain |
| 05/26/2004 | EP1421089A1 4-THIOXO-4,7-DIHYDRO-THIENO 2,3-b]PYRIDINE-5-CARBOXAMIDES AS ANTIVIRAL AGENTS |
| 05/26/2004 | EP1421088A1 4-thioxo-4,7-dihydro-thieno 2,3-b]pyridine-5-carbothioamides as antiviral agents |
| 05/26/2004 | EP1421087A1 Diazacycloalkanes as oxytocin agonists |
| 05/26/2004 | EP1420785A2 SUBSTITUTED INDENO 1,2-c]ISOQUINOLINE DERIVATIVES AND METHODS OF USE THEREOF |
| 05/26/2004 | EP1420780A2 Cyclopropyl and cyclobutyl epothilone analogs |
| 05/26/2004 | EP1119359B1 2-methyl-thieno-benzodiazepine formulation |
| 05/26/2004 | CN1500089A Fused pyridine derivatives for use as vanilloid receptor antagonists for treating pain |
| 05/26/2004 | CN1500087A 哒嗪酮醛糖还原酶抑制剂 Pyridazinone aldose reductase inhibitors |
| 05/26/2004 | CN1500080A 稠合杂环化合物 Fused heterocyclic compounds |
| 05/26/2004 | CN1499974A Remedies for vesical stimulation in association with prostatauxe |
| 05/26/2004 | CN1499969A pharmaceutical formulation contg. pyrazolo[4,3-D] pyrimidine and nitrates or thienopyrimidines and nitrates |
| 05/25/2004 | US6740753 Crystal olanzapine with a melting point of 187-191 degrees c. |
| 05/25/2004 | US6740663 Mono- and di-fluorinated benzothiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (ASBT) and taurocholate uptake |
| 05/25/2004 | US6740654 Inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immune or inflammatory disorders, or disorders involving the inappropriate growth or migration of cells. |
| 05/21/2004 | WO2004041830A2 An improved process for the preparation of biotin |
| 05/21/2004 | WO2004041818A1 Anti-infective agents |
| 05/21/2004 | WO2004041780A2 N-(indole-2-carbonyl) amides as anti-diabetic agents |
| 05/21/2004 | WO2004041776A2 SULFONYLAMINOVALEROLAC TAMS AND DERIVATIVES THEREOF AS FACTOR Xa INHIBITORS |
| 05/21/2004 | WO2004041285A1 Antiinflammation agents |
| 05/21/2004 | WO2004041162A2 Inhibitors of akt activity |
| 05/21/2004 | CA2503727A1 Anti-diabetic agents |
| 05/21/2004 | CA2502429A1 Antiinflammation agents |
| 05/20/2004 | US20040097741 3,4-alkylenedioxythiophenedioxide compounds and polymers comprising monomeric units thereof |
| 05/20/2004 | US20040097525 Novel Compounds |
| 05/20/2004 | US20040097524 For therapy and prophylaxis of disorder in which the blocking of purine receptors, particularly adenosine receptors and more may be beneficial, such a Parkinson's disease or depression, cognitive or memory impairment, pain |
| 05/20/2004 | US20040097501 Triazole compounds useful as protein kinase inhibitors |
| 05/20/2004 | US20040097492 For inhibiting hepatitis C virus (HCV) polymerase; therapy and prophylaxis of HCV infection |
| 05/20/2004 | US20040097489 2-methyl-thieno-benzodiazepine formulation |
| 05/20/2004 | US20040097485 For therapy and prophylaxis of disease or condition associated with inflammation, a metabolic disorder, infection, cancer or an immune disease or condition |
| 05/20/2004 | US20040097438 Fused-ring compounds and use thereof as drugs |
| 05/20/2004 | US20040094753 Photochromic compound exhibits absorption bands in two wavelength regions of 440 to 500 nm and 570 to 630 nm. |
| 05/19/2004 | EP1419772A1 Preventive agent/remedial agent for constipation predominant ibs |
| 05/19/2004 | EP1025102B1 Bicyclic kinase inhibitors |
| 05/19/2004 | EP0717736B1 Phosphorus derivatives to treat aids |
| 05/19/2004 | DE10250708A1 Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel New alkyne compounds with MCH-antagonistic activity and pharmaceutical compositions containing them |
| 05/19/2004 | CN1498110A Remedies for vesical hyperfunction |
| 05/19/2004 | CN1498109A Remedies for cysterethsm |
| 05/19/2004 | CN1496981A Cycloamine derivative and its use as medicine |
| 05/19/2004 | CN1150198C Process for producing hexahydrothiopheno-[3,4-d]imidzaole-2,4-diketones compound |
| 05/19/2004 | CN1150197C Naphtho- and dihydrobenzo-thiopyhene derivatives as cytotoxic antitumor agents |
| 05/18/2004 | US6737424 Alpha-substituted pyridazino quinoline compounds |
| 05/18/2004 | US6737256 Generating preferential compound in culture; obtain genetically engineered bacteria, culturing, recover preferential compound |
| 05/13/2004 | WO2004039780A1 Novel alkyne compounds having an mch antagonistic effect and medicaments containing these compounds |
| 05/13/2004 | WO2004024065A3 Substituted bicyclic thiophene derivatives, compostions containing such compounds and methods of use |
| 05/13/2004 | US20040092743 Indeno(2,1-f) chromene derivatives for ophthalmic lenses |
| 05/13/2004 | US20040092740 Hyperpermeability; diabetic retinopathy, ischemic retinal-vein occlusion, prematurity, age-related macular degeneration |
| 05/13/2004 | US20040092576 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 05/13/2004 | US20040092573 Anticholesterol agents |
| 05/13/2004 | DE10250082A1 Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel Selected CGRP antagonists, processes for their preparation and their use as medicaments |
| 05/13/2004 | DE10250080A1 Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel Selected CGRP antagonists, processes for their preparation and their use as medicaments |
| 05/12/2004 | EP1265903B1 Thiepino[3,2-b]dihydropyridines and related compositions and methods |
| 05/12/2004 | EP1036065B1 Substituted imidazole derivatives having agonist-like activity at alpha 2b or 2b/2c adrenergic receptors |
| 05/12/2004 | EP1018514B1 NF-$g(k)B INHIBITORS CONTAINING INDAN DERIVATIVES AS THE ACTIVE INGREDIENT |
| 05/12/2004 | EP0927192B1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production |
| 05/12/2004 | CN1495186A Method for preparing enkephalinase and angiotensin-converting enzyme inhibitor intermediate and its intermediate |
| 05/12/2004 | CN1495172A Irreversible inhibitor of tyrosine kinase |
| 05/12/2004 | CN1495170A Substituted pyrazolyl benzsulfamide compound for curing inflammation |
| 05/12/2004 | CN1494907A Drug composition for curing pain |
| 05/12/2004 | CN1149216C Tricylic benzoylcylohexanedione derivatives |
| 05/11/2004 | US6734312 Process for preparing a compound containing a heteroaromatic group with one or more ether substituents |
| 05/11/2004 | US6734203 Fused imidazolium derivatives |
| 05/11/2004 | US6734189 Hydroxamic and carboxylic acid derivatives |
| 05/11/2004 | US6734180 NF-κB inhibitor comprising an indan derivative as an active ingredient |
| 05/06/2004 | WO2004037828A1 Process for producing optically active sulfoxide |
| 05/06/2004 | WO2004037811A1 Selected cgrp antagonists, method for production and use thereof as medicament |
| 05/06/2004 | WO2004037810A1 Selected cgrp antagonists, method for production and use thereof as medicament |
| 05/06/2004 | WO2004022537A3 Thienopyrrolyl and furanopyrrolyl compounds and their use as histamine h4 receptor ligands |
| 05/06/2004 | WO2003040096A3 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 05/06/2004 | US20040087800 Spirooxindole derivatives are analgesics for the treatment of chronic pain. |
| 05/06/2004 | US20040087646 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 05/06/2004 | US20040087639 6,7-Dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which provide analgesia |
| 05/06/2004 | US20040087577 Anti-infective agents |
| 05/06/2004 | US20040087552 Pyrrolidine modulators of ccr5 chemokine receptor activity |
| 05/06/2004 | EP1415995A2 Photocleavable agents and conjugates for the detection and isolation of biomolecules |
| 05/06/2004 | EP1415993A1 Clopidogrel salts with alkyl-sulphuric acids |
| 05/06/2004 | EP1415992A1 Diamine derivatives |
| 05/06/2004 | EP1415987A1 Nitrogenous aromatic ring compounds |
| 05/06/2004 | EP1415651A1 Preventives/remedies for cholinergic neuropathy |
| 05/06/2004 | EP1414825A1 Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 05/06/2004 | EP1414817A1 Substituted isoindoles and e use thereof |
| 05/06/2004 | EP1414813A1 1,2,4-trioxolane antimalarials |
| 05/06/2004 | EP1414522A2 Carbonic anhydrase inhibitors |
| 05/06/2004 | EP0589004B2 Process for the determination of peptides corresponding to immunologically important epitopes of hcv |
| 05/06/2004 | CA2503520A1 Process for producing optically active sulfoxide |
| 05/06/2004 | CA2503462A1 Selected cgrp antagonists, processes for preparing them and their use aspharmaceutical compositions |
| 05/06/2004 | CA2503455A1 Selected cgrp antagonists, method for production and use thereof as medicament |
| 05/05/2004 | CN1493291A Dicyclic compound capable of inhibiting epidermis growth factor acceptor rotatory tyrosine kinase |
| 05/04/2004 | US6730694 sPLA2 inhibitors |
| 05/04/2004 | US6730668 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
| 04/29/2004 | WO2004035591A1 Anthelmintic and insecticidal thiohene compositions |
| 04/29/2004 | WO2004035589A1 Heterocyclocarboxamide derivatives |
| 04/29/2004 | WO2004035581A1 Spiroheterocyclic derivative compounds and drugs comprising the compounds as the active ingredient |
| 04/29/2004 | WO2004035580A1 Reactivation of wild type p53 in human tumour cells by a low molecular weight compound |
| 04/29/2004 | WO2003099823A3 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |